Richard Drew / AP

Wall Street is closely following the House vote on the American Health Care Act. Health care stocks are almost guaranteed to move in one way or the other next week, depending what happens this afternoon.

But the House vote is just the beginning. "Wall Street seems to understand that the House bill is not the final product, and some of the draconian measures that are most negative to the group almost certainly will be removed to get the bill through the Senate," Spencer Perlman and Sumesh Sood of investment research firm Veda Partners said in a research note Friday.

Here's what could happen to health care stocks in the short term.

If the bill passes the House:

  • Hospital companies (HCA, Tenet Healthcare, LifePoint Health, Community Health Systems, Universal Health Services) could suffer since Trumpcare would increase uncompensated care.
  • Health insurers that focus on Medicaid (Centene, Molina Healthcare, WellCare Health Plans) could trade down since the bill would phase out Medicaid expansion.
  • Medical device companies (Stryker, C.R. Bard, Zimmer Biomet, Boston Scientific) could trade higher since Trumpcare permanently repeals the device tax.
  • Drug companies may not move much, since the bill doesn't tinker with pricing.

If the bill fails:

  • Hospital stocks would "experience a significant relief rally," Mizuho Securities analyst Sheryl Skolnick said in a note Friday. Medicaid companies would, too. But hospitals would still struggle with high labor costs and declining admissions.
  • The failed vote could threaten tax reform and could drive down many other health care stocks that would benefit from that, Perlman and Sood said. Pharmaceutical companies clearly want tax reform. The large health insurance companies (Aetna, Anthem, Cigna, Humana, UnitedHealth Group) — which derive all their earnings in the United States and usually have a tax rate around 40% — also badly want the corporate tax rate lowered to at least half that.

Go deeper

20 Republican former U.S. attorneys endorse Biden, call Trump "a threat to the rule of law"

Photo: Mandel Ngan/AFP via Getty Images

Twenty Republican former U.S. Attorneys on Tuesday endorsed Joe Biden while saying that "President Trump's leadership is a threat to rule of law" in the U.S., the Washington Post reports.

What they're saying: In the letter, the former prosecutors criticize Trump's use of the Department of Justice, saying the president expects the DOJ to "to serve his personal and political interests."

  • "He has politicized the Justice Department, dictating its priorities along political lines and breaking down the barrier that prior administrations had maintained between political and prosecutorial decision-making," the letter says.
Updated 29 mins ago - Politics & Policy

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Politics: Axios-Ipsos poll: Federal response has only gotten worse — The swing states where the pandemic is raging.
  2. Health: The coronavirus is starting to crush some hospitals — 13 states set single-day case records last week.
  3. Business: Winter coronavirus threat spurs new surge of startup activity.
  4. Media: Pandemic causes cable and satellite TV providers to lose the most subscribers ever.
  5. States: Nearly two dozen Minnesota COVID cases traced to 3 Trump campaign events.
  6. World: Unrest in Italy as restrictions grow across Europe.

Ted Cruz defends GOP's expected return to prioritizing national debt

Sen. Ted Cruz (R-Texas) told "Axios on HBO" on Monday that he wishes reining in the national debt was a higher priority for President Trump.

Why it matters: Trump pledged during the 2016 campaign to reduce the national debt and eliminate it entirely within eight years, though he also deemed himself "the king of debt" and said there were some priorities that required spending. In the fiscal year that ended in September, the deficit reached a record $3.1 trillion.